All of Us Research Program returns first genetic results to participants
Participants who donated biosamples, as part of the historic “All of Us” Research Program, may soon see a return of their genetic results.
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children’s Hospital
A first-in-humans clinical trial for children with relapsed or refractory neuroblastoma has opened at American Family Children’s Hospital (AFCH) and is being conducted by researchers at University of Wisconsin School of Medicine and Public Health. Neuroblastoma is one of the most common solid tumors in children. Patients who are classified as “high-risk” (about 40 percent of those diagnosed) have less than a 50 percent survival rate.
UW set to resume enrollment for AstraZeneca’s investigational COVID-19 vaccine
A clinical trial of an investigational COVID-19 vaccine has resumed in the United States after the FDA and an independent safety review board completed their review of a trial participant in the United Kingdom who became ill.
AstraZeneca COVID-19 vaccine clinical trial resumes at UW
AstraZeneca announced that the COVID-19 vaccine trial has resumed in the United States, including at UW Health and the UW School of Medicine and Public Health, after the FDA and an independent safety review board completed their review of an illness contracted by a trial participant in the United Kingdom.
UW Health and UW School of Medicine and Public Health launch new Study Finder
UW Health and the UW School of Medicine and Public Health have launched the UW Health Study Finder, a new, easily accessible website that lists UW studies and clinical trials that are currently recruiting participants.
UW Carbone Cancer Center receives FDA clearance to test new regenerative medicine therapy for radiotherapy-induced dry mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy.
UW Health and University of Wisconsin selected as one of first clinical sites in the U.S. to test new COVID-19 vaccine
UW Health and the University of Wisconsin School of Medicine and Public Health (SMPH) are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2.
Three COVID-19 clinical trials move forward at UW
The University of Wisconsin School of Medicine and Public Health and UW Health will conduct three clinical trials to test a new treatment and preventative for COVID-19, in collaboration with Regeneron Pharmaceuticals.
‘COVID toes’ clinical trial underway at UW School of Medicine and Public Health
A team of researchers at the University of Wisconsin School of Medicine and Public Health is studying how the skin condition referred to as “COVID toes” is a connected to the virus, whether it is symptom of a COVID-19 infection or an immune response to the virus.
First COVID-19 patient at University Hospital treated with plasma from recovered patient
A COVID-19 patient at UW Hospital has received the first transfusion of plasma from a local patient who donated it since recovering from the disease.
Scoring system predicts seizure risk in hospitalized patients
A new rating system can accurately predict which critically ill patients are in danger of having seizures while hospitalized, a large, multi-national trial shows.
Inflammation predicts response to anti-depression medication
Children and teens with bipolar depression responded better to an antipsychotic medicine if they had increased markers of inflammation in their blood, a new University of Wisconsin–Madison study shows.